Back to News
investment
Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO
Bailey Lipschultz
Loading...
1 min read
0 likes
Quantum News · Media Library
Understand this faster with AI
Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering.
Tags
quantum-investment
Source Information
Source: Bloomberg
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.